{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:54:35Z","timestamp":1790362475732,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myocardial ischemia reperfusion (I\/R) injury is a complex process with intense inflammatory response and cardiomyocyte apoptosis. As a decoy receptor of IL-1\u03b2, Interleukin-1 receptor type 2 (IL-1R2) inhibits IL-1\u03b2 signaling. However, its role in I\/R injury remains unknown. Here we found that the serum levels of IL-1R2 were significantly increased in patients with acute myocardial infarction (AMI) following interventional therapy. Similarly, after myocardial I\/R surgery, IL-1R2 expression was significantly increased in heart of wild-type mice. In addition, IL-1R2-deficient mice heart showed enlarged infarct size, increased cardiomyocyte apoptosis together with reduced cardiac systolic function. Following exposure to hypoxia and reoxygenation (H\/R), neonatal rat ventricular myocytes (NRVM) significantly increased IL-1R2 expression relying on NF-\u03baB activation. Consistently, IL-1R2-deficient mice increased immune cells infiltrating into heart after surgery, which was relevant with cardiac damage. Additionally, IL-1R2 overexpression in cardiomyocyte protected cardiomyocyte against apoptosis through reducing the IL-17RA expression both in vivo and in vitro. Our results indicate that IL-1R2 protects cardiomyocytes from apoptosis, which provides a therapeutic approach to turn down myocardial I\/R injury.<\/jats:p>","DOI":"10.1038\/s41419-022-04533-1","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T10:02:56Z","timestamp":1643277776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cardiomyocyte IL-1R2 protects heart from ischemia\/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Jun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-505X","authenticated-orcid":false,"given":"Qingbo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4511-4290","authenticated-orcid":false,"given":"Min","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4606-2835","authenticated-orcid":false,"given":"Yanbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-0717","authenticated-orcid":false,"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"4533_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56\u2013e528.","journal-title":"Circulation"},{"key":"4533_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N. Engl J Med. 2007;357:1121\u201335.","journal-title":"N. Engl J Med"},{"key":"4533_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92\u2013100.","journal-title":"J Clin Invest"},{"key":"4533_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.amjcard.2010.03.032","volume":"106","author":"AT Turer","year":"2010","unstructured":"Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106:360\u20138.","journal-title":"Am J Cardiol"},{"key":"4533_CR5","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.bbamcr.2016.08.013","volume":"1863","author":"SA Su","year":"2016","unstructured":"Su SA, Yang D, Zhu W, Cai Z, Zhang N, Zhao L, et al. Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway. Biochim Biophys Acta. 2016;1863:2784\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"4533_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/toxsci\/kfs106","volume":"127","author":"X Wang","year":"2012","unstructured":"Wang X, Liu Q, Ihsan A, Huang L, Dai M, Hao H, et al. JAK\/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin. Toxicological Sci. 2012;127:412\u201324.","journal-title":"Toxicological Sci"},{"key":"4533_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017;15:23.","journal-title":"Cell Commun Signal"},{"key":"4533_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0543-8","volume":"111","author":"KE O\u2019Sullivan","year":"2016","unstructured":"O\u2019Sullivan KE, Breen EP, Gallagher HC, Buggy DJ, Hurley JP. Understanding STAT3 signaling in cardiac ischemia. Basic Res Cardiol. 2016;111:27.","journal-title":"Basic Res Cardiol"},{"key":"4533_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/cvr\/cvn067","volume":"79","author":"N Suleman","year":"2008","unstructured":"Suleman N, Somers S, Smith R, Opie LH, Lecour SC. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res. 2008;79:127\u201333.","journal-title":"Cardiovasc Res"},{"key":"4533_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1582-4934.2011.01323.x","volume":"16","author":"J McCormick","year":"2012","unstructured":"McCormick J, Suleman N, Scarabelli TM, Knight RA, Latchman DS, Stephanou A. STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. J Cell Mol Med. 2012;16:386\u201393.","journal-title":"J Cell Mol Med"},{"key":"4533_CR11","doi-asserted-by":"publisher","first-page":"28340","DOI":"10.1074\/jbc.M101177200","volume":"276","author":"A Stephanou","year":"2001","unstructured":"Stephanou A, Scarabelli TM, Brar BK, Nakanishi Y, Matsumura M, Knight RA, et al. Induction of apoptosis and Fas receptor\/Fas ligand expression by ischemia\/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem. 2001;276:28340\u20137.","journal-title":"J Biol Chem"},{"key":"4533_CR12","doi-asserted-by":"publisher","first-page":"10002","DOI":"10.1074\/jbc.275.14.10002","volume":"275","author":"A Stephanou","year":"2000","unstructured":"Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS, et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem. 2000;275:10002\u20138.","journal-title":"J Biol Chem"},{"key":"4533_CR13","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/CIRCULATIONAHA.113.003199","volume":"128","author":"BW Van Tassell","year":"2013","unstructured":"Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation. 2013;128:1910\u201323.","journal-title":"Circulation"},{"key":"4533_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/eurjhf\/hfq017","volume":"12","author":"A Abbate","year":"2010","unstructured":"Abbate A, Van Tassell BW, Seropian IM, Toldo S, Robati R, Varma A, et al. Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur J Heart Fail. 2010;12:319\u201322.","journal-title":"Eur J Heart Fail"},{"key":"4533_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00109-018-1684-z","volume":"96","author":"T Schluter","year":"2018","unstructured":"Schluter T, Schelmbauer C, Karram K, Mufazalov IA. Regulation of IL-1 signaling by the decoy receptor IL-1R2. J Mol Med (Berl). 2018;96:983\u201392.","journal-title":"J Mol Med (Berl)"},{"key":"4533_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1172\/JCI118045","volume":"96","author":"D Burger","year":"1995","unstructured":"Burger D, Chicheportiche R, Giri JG, Dayer JM. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest. 1995;96:38\u201341.","journal-title":"J Clin Invest"},{"key":"4533_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1074-7613(02)00514-9","volume":"18","author":"DE Smith","year":"2003","unstructured":"Smith DE, Hanna R, Della F, Moore H, Chen H, Farese AM, et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity. 2003;18:87\u201396.","journal-title":"Immunity"},{"key":"4533_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1189\/jlb.0113035","volume":"94","author":"P Martin","year":"2013","unstructured":"Martin P, Palmer G, Vigne S, Lamacchia C, Rodriguez E, Talabot-Ayer D, et al. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions. J Leukoc Biol. 2013;94:791\u2013802.","journal-title":"J Leukoc Biol"},{"key":"4533_CR19","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.4049\/jimmunol.1402155","volume":"194","author":"K Shimizu","year":"2015","unstructured":"Shimizu K, Nakajima A, Sudo K, Liu Y, Mizoroki A, Ikarashi T, et al. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages. J Immunol. 2015;194:3156\u201368.","journal-title":"J Immunol"},{"key":"4533_CR20","doi-asserted-by":"publisher","first-page":"1901728","DOI":"10.1002\/advs.201901728","volume":"7","author":"L Zhang","year":"2020","unstructured":"Zhang L, Qiang J, Yang X, Wang D, Rehman AU, He X, et al. IL1R2 blockade suppresses breast tumorigenesis and progression by impairing USP15-dependent BMI1 stability. Adv Sci (Weinh). 2020;7:1901728.","journal-title":"Adv Sci (Weinh)"},{"key":"4533_CR21","doi-asserted-by":"publisher","first-page":"22212","DOI":"10.1074\/jbc.M115.644823","volume":"290","author":"AC Mar","year":"2015","unstructured":"Mar AC, Chu CH, Lee HJ, Chien CW, Cheng JJ, Yang SH, et al. Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce angiogenesis. J Biol Chem. 2015;290:22212\u201324.","journal-title":"J Biol Chem"},{"key":"4533_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/CIRCRESAHA.117.312641","volume":"122","author":"X Bi","year":"2018","unstructured":"Bi X, Zhang G, Wang X, Nguyen C, May HI, Li X, et al. Endoplasmic reticulum chaperone GRP78 protects heart from ischemia\/reperfusion injury through Akt activation. Circ Res. 2018;122:1545\u201354.","journal-title":"Circ Res"},{"key":"4533_CR23","first-page":"111","volume":"1","author":"RA Knight","year":"2012","unstructured":"Knight RA, Scarabelli TM, Stephanou A. STAT transcription in the ischemic heart. Jakstat. 2012;1:111\u20137.","journal-title":"Jakstat"},{"key":"4533_CR24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/bph.13673","volume":"174","author":"A Cipak Gasparovic","year":"2017","unstructured":"Cipak Gasparovic A, Zarkovic N, Zarkovic K, Semen K, Kaminskyy D, Yelisyeyeva O, et al. Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches. Br J Pharm. 2017;174:1771\u201383.","journal-title":"Br J Pharm"},{"key":"4533_CR25","doi-asserted-by":"publisher","first-page":"6501046","DOI":"10.1155\/2017\/6501046","volume":"2017","author":"I Marrocco","year":"2017","unstructured":"Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017:6501046.","journal-title":"Oxid Med Cell Longev"},{"key":"4533_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/ni1392","volume":"7","author":"A Ariel","year":"2006","unstructured":"Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol. 2006;7:1209\u201316.","journal-title":"Nat Immunol"},{"key":"4533_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159\u201373.","journal-title":"Circ Res"},{"key":"4533_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcvm.2018.00143","volume":"5","author":"F Perbellini","year":"2018","unstructured":"Perbellini F, Watson SA, Bardi I, Terracciano CM. Heterocellularity and cellular cross-talk in the cardiovascular system. Front Cardiovasc Med. 2018;5:143.","journal-title":"Front Cardiovasc Med"},{"key":"4533_CR29","doi-asserted-by":"crossref","unstructured":"Bageghni SA, Hemmings KE, Yuldasheva NY, Maqbool A, Gamboa-Esteves FO, Humphreys NE, et al. Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction. JCI Insight 2019;5:e125074.","DOI":"10.1172\/jci.insight.125074"},{"key":"4533_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/157340309788970405","volume":"5","author":"DJ Kaczorowski","year":"2009","unstructured":"Kaczorowski DJ, Nakao A, McCurry KR, Billiar TR. Toll-like receptors and myocardial ischemia\/reperfusion, inflammation, and injury. Curr Cardiol Rev. 2009;5:196\u2013202.","journal-title":"Curr Cardiol Rev"},{"key":"4533_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.npep.2010.10.002","volume":"45","author":"EN Alston","year":"2011","unstructured":"Alston EN, Parrish DC, Hasan W, Tharp K, Pahlmeyer L, Habecker BA. Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms. Neuropeptides. 2011;45:33\u201342.","journal-title":"Neuropeptides"},{"key":"4533_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2018.05.032","volume":"268","author":"HL Orrem","year":"2018","unstructured":"Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, et al. Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction. Int J Cardiol. 2018;268:187\u201392.","journal-title":"Int J Cardiol"},{"key":"4533_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2012.11.006","volume":"32","author":"VA Peters","year":"2013","unstructured":"Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun. 2013;32:1\u20138.","journal-title":"Brain Behav Immun"},{"key":"4533_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/mi.2015.108","volume":"9","author":"R Mora-Buch","year":"2016","unstructured":"Mora-Buch R, Dotti I, Planell N, Calder\u00f3n-G\u00f3mez E, Jung P, Masamunt MC, et al. Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis. Mucosal Immunol. 2016;9:950\u20139.","journal-title":"Mucosal Immunol"},{"key":"4533_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1113\/expphysiol.2012.069831","volume":"98","author":"S Toldo","year":"2013","unstructured":"Toldo S, Mezzaroma E, Van Tassell BW, Farkas D, Marchetti C, Voelkel NF, et al. Interleukin-1\u03b2 blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse. Exp Physiol. 2013;98:734\u201345.","journal-title":"Exp Physiol"},{"key":"4533_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.amjcard.2014.11.003","volume":"115","author":"A Abbate","year":"2015","unstructured":"Abbate A, Kontos MC, Abouzaki NA, Melchior RD, Thomas C, Van Tassell BW, et al. Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies). Am J Cardiol. 2015;115:288\u201392.","journal-title":"Am J Cardiol"},{"key":"4533_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","volume":"59","author":"YH Liao","year":"2012","unstructured":"Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, Lv BJ, et al. Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol. 2012;59:420\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"4533_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijcard.2011.08.849","volume":"163","author":"SP Barry","year":"2013","unstructured":"Barry SP, Ounzain S, McCormick J, Scarabelli TM, Chen-Scarabelli C, Saravolatz LII, et al. Enhanced IL-17 signalling following myocardial ischaemia\/reperfusion injury. Int J Cardiol. 2013;163:326\u201334.","journal-title":"Int J Cardiol"},{"key":"4533_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"G Frati","year":"2017","unstructured":"Frati G, Schirone L, Chimenti I, Yee D, Biondi-Zoccai G, Volpe M, et al. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc Res. 2017;113:378\u201388.","journal-title":"Cardiovasc Res"},{"key":"4533_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.RES.84.1.21","volume":"84","author":"DJ Ing","year":"1999","unstructured":"Ing DJ, Zang J, Dzau VJ, Webster KA, Bishopric NH. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res. 1999;84:21\u201333.","journal-title":"Circ Res"},{"key":"4533_CR41","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/jid.2011.222","volume":"131","author":"X Shi","year":"2011","unstructured":"Shi X, Jin L, Dang E, Chang T, Feng Z, Liu Y, et al. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. J Invest Dermatol. 2011;131:2401\u20138.","journal-title":"J Invest Dermatol"},{"key":"4533_CR42","doi-asserted-by":"publisher","first-page":"e69585","DOI":"10.1371\/journal.pone.0069585","volume":"8","author":"S Pugazhenthi","year":"2013","unstructured":"Pugazhenthi S, Zhang Y, Bouchard R, Mahaffey G. Induction of an inflammatory loop by interleukin-1\u03b2 and tumor necrosis factor-\u03b1 involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells. PLoS One. 2013;8:e69585.","journal-title":"PLoS One"},{"key":"4533_CR43","doi-asserted-by":"publisher","first-page":"C1640","DOI":"10.1152\/ajpcell.1998.275.6.C1640","volume":"275","author":"AR Simon","year":"1998","unstructured":"Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998;275:C1640\u20131652.","journal-title":"Am J Physiol"},{"key":"4533_CR44","first-page":"305","volume":"52","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yu X, Song H, Feng D, Jiang Y, Wu S, et al. The STAT-ROS cycle extends IFN\u2011induced cancer cell apoptosis. Int J Oncol. 2018;52:305\u201313.","journal-title":"Int J Oncol"},{"key":"4533_CR45","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1096\/fj.06-6188fje","volume":"20","author":"J McCormick","year":"2006","unstructured":"McCormick J, Barry SP, Sivarajah A, Stefanutti G, Townsend PA, Lawrence KM, et al. Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia\/reperfusion injury. Faseb j. 2006;20:2115\u20137.","journal-title":"Faseb j"},{"key":"4533_CR46","doi-asserted-by":"publisher","first-page":"H1932","DOI":"10.1152\/ajpheart.00755.2010","volume":"301","author":"X Li","year":"2011","unstructured":"Li X, Mikhalkova D, Gao E, Zhang J, Myers V, Zincarelli C, et al. Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage density. Am J Physiol Heart Circ Physiol. 2011;301:H1932\u20131940.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4533_CR47","first-page":"1","volume":"5","author":"J Rutering","year":"2015","unstructured":"Rutering J, Ilmer M, Recio A, Coleman M, Vykoukal J, Alt E. Improved method for isolation of neonatal rat cardiomyocytes with increased yield of C-Kit+ cardiac progenitor cells. J Stem Cell Res Ther. 2015;5:1\u20138.","journal-title":"J Stem Cell Res Ther"},{"key":"4533_CR48","doi-asserted-by":"publisher","unstructured":"Vandergriff AC, Hensley MT, Cheng K. Isolation and cryopreservation of neonatal rat cardiomyocytes. J Vis Exp. 2015. https:\/\/doi.org\/10.3791\/52726.","DOI":"10.3791\/52726"},{"key":"4533_CR49","doi-asserted-by":"publisher","first-page":"114065","DOI":"10.1016\/j.bcp.2020.114065","volume":"178","author":"J Wang","year":"2020","unstructured":"Wang J, Xue Z, Lin J, Wang Y, Ying H, Lv Q, et al. Proline improves cardiac remodeling following myocardial infarction and attenuates cardiomyocyte apoptosis via redox regulation. Biochem Pharm. 2020;178:114065.","journal-title":"Biochem Pharm"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04533-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04533-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:01:54Z","timestamp":1669302114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04533-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["4533"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04533-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"11 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}